The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma.Kathrine T Isaksen,Klaus Beiske,Erlend B Smeland,Judit Jørgensen,Marianne Brodtkorb,June Helen Myklebust,Mats Jerkeman,Leo Meriranta,Marja-Liisa Karjalainen-Lindsberg,Sirpa Leppä,David W Scott,Harald Holte,Yngvild Nuvin BlakereJHaem（2020）引用 2|浏览8暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
